Back to
Trexquant Investment LP
PLRX
Showing 3 of 12 quarters
Position history for
Trexquant Investment LP's holdings in Pliant Therapeutics, Inc.
No. Trexquant Investment exited its PLRX (Pliant Therapeutics) position in Q1 2025. Its Q4 2024 13F listed 62,477 shares worth $822,822. Trexquant Investment first reported PLRX in Q1 2022 and held it in 10 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$973,611
Total Shares Change
-86,852
Quarter-by-Quarter History